Back to feed
TechCrunch AI
TechCrunch AI
7/15/2026
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Short summary

OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2 billion. Lightspeed is reportedly in discussions to lead the funding round. Details are sparse beyond the valuation and lead investor.

  • •OpenAI researcher Miles Wang launching AI drug discovery startup
  • •Targeting a $2B valuation with Lightspeed potentially leading the round
  • •No further details on product, timeline, or other investors disclosed

Generated with AI, which can make mistakes.

#funding-acquisition#industry-adoption
Read full article at TechCrunch AI

Is this a good recommendation for you?

Comments

Failed to load comments. Please try again.

Explore more

Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery
Economic Times Tech
Google’s Isomorphic Labs to raise over $2 billion in new funding
Economic Times Tech
Isomorphic Labs secures $2B+ Series C funding from Thrive Capital for AI drug discovery
Economic Times Tech
AI dictation startup Wispr in funding talks at $2 billion value
Economic Times Tech